Literature DB >> 7489800

Chronic mucus hypersecretion in COPD and death from pulmonary infection.

E Prescott1, P Lange, J Vestbo.   

Abstract

The association of chronic mucus hypersecretion and mortality is a matter of debate. We wished to determine whether the relationship between chronic mucus hypersecretion and chronic obstructive pulmonary disease (COPD)-related mortality could be explained by proneness to pulmonary infection. We followed 14,223 subjects of both sexes for 10-12 yrs. Cases where COPD was an underlying or contributory cause of death (n = 214) were included, and hospital records were obtained when possible (n = 101). From the presence of increased mucus, purulent mucus, fever, leucocytosis and infiltration on chest radiography, death was classified as either due to pulmonary infection (n = 38), other causes (n = 51), or unclassifiable (n = 12). Of subjects reporting chronic mucus hypersecretion at the initial examination, pulmonary infection was implicated in 54% of deaths, whereas this only occurred in 28% of subjects without chronic mucus hypersecretion. Controlling for covariates, in particular smoking habits, a Cox analysis showed a strong inverse relationship between ventilatory function and COPD-related mortality. Chronic mucus hypersecretion was found to be a significant predictor of COPD-related death with pulmonary infection implicated (relative risk (RR) 3.5) but not of death without pulmonary infection (RR 0.9). We consider that subjects with COPD and chronic mucus hypersecretion are more likely to die from pulmonary infections than subjects without chronic mucus hypersecretion. This may explain the excess mortality in subjects with COPD and chronic mucus hypersecretion found in previous studies.

Entities:  

Mesh:

Year:  1995        PMID: 7489800     DOI: 10.1183/09031936.95.08081333

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  60 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Airway mucus: From production to secretion.

Authors:  Olatunji W Williams; Amir Sharafkhaneh; Victor Kim; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

3.  Chronic productive cough is associated with death in smokers with early COPD.

Authors:  Nirupama Putcha; M Bradley Drummond; John E Connett; Paul D Scanlon; Donald P Tashkin; Nadia N Hansel; Robert A Wise
Journal:  COPD       Date:  2013-10-15       Impact factor: 2.409

4.  Chronic Bronchitis in Chronic Obstructive Pulmonary Disease. Magnifying Why Smoking Cessation Still Matters Most.

Authors:  Sharon R Rosenberg; Ravi Kalhan
Journal:  Ann Am Thorac Soc       Date:  2016-07

5.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

Review 6.  The role of CLCA proteins in inflammatory airway disease.

Authors:  Anand C Patel; Tom J Brett; Michael J Holtzman
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

7.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

Review 8.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 10.  Newer fluoroquinolones in the treatment of acute exacerbations of COPD.

Authors:  Amit Patel; Robert Wilson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.